End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis

Am J Respir Crit Care Med. 2011 Jul 1;184(1):4-5. doi: 10.1164/rccm.201105-0813ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Bosentan
  • Endothelin Receptor Antagonists*
  • Endpoint Determination
  • Humans
  • Idiopathic Pulmonary Fibrosis / drug therapy*
  • Idiopathic Pulmonary Fibrosis / physiopathology
  • Sulfonamides / therapeutic use*
  • Treatment Outcome

Substances

  • Antihypertensive Agents
  • Endothelin Receptor Antagonists
  • Sulfonamides
  • Bosentan